No Patient Left Behind: Connecting Rare Disease Patients to Orphan Drug Manufacturers

podcast MM&M Partner Perspectives

No Patient Left Behind: Connecting Rare Disease Patients to Orphan Drug Manufacturers
  • Language: eng
  • Published: 27 Jul 2016
  • Duration: 10:38

Marc Iskowitz, MM&M's editor in chief, discusses a qualitative/quantitative approach to meeting orphan drug marketers' engagement challenge with Michael Carlin, vice president at TrialCard.